Genomics Technology Company, Simplify Genomics, Emerges from Development Mode by leveraging the infrastructure developed at Genomic Sequencing Pioneer Human Longevity with the launch of a Searchable Genome, Interpretation, and Reporting Platform Called Smart GenomeTM.
Simplify Genomics, Inc. relaunches a beta genome search engine and reduces hosting costs by 95%. The genome search engine allows clinicians to explore complete genomes with a user-friendly interface that can query hundreds of millions of genomic variants at the… Read More »Simplify Genomics Launches Genome Search Engine
HLI launches CLIA-verified and CAP-accredited Whole Genome report for clinical screening.
Human Longevity, Inc. (HLI), the genomic-driven health information technology company, announces that the company has received certification under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
HLI acquires Cypher Genomics informatics company founded by Ashley Van Zeeland, Ali Torkamani, Nicholas Schork, and Eric Topol.
Simplify Genomics, Inc. releases its 8th major revision of the Genomic Clinical Report, significantly increasing the scope of gene-disease associations covered.
Simplify Genomics, Inc., a genomics-technology company, establishes its Scientific Advisory Board with Dr. Richard Cote, Chair of Pathology and Immunology at Washington University. With the addition of Dr. Cote, Simplify Genomics gains deep expertise in clinical pathology and in the… Read More »Simplify Genomics establishes SAB with Dr Richard Cote
Human Longevity, Inc. spins out the genomics reporting and research division to form a new company, Simplify Genomics, Inc. Simplify Genomics migrates genomics data, workflows, and supporting infrastructure to establish independent operations for clinical Whole Genome Sequencing and R&D.
Human Longevity, Inc. announces a $30 million financing led by Emerging Technology Partners, LLC. Proceeds from the financing are to be used to enhance the Health Nucleus Platform.
Human Longevity, Inc. develops a novel approach for streamlining germline variant interpretation in accordance with industry standards.